Terbinex with Eco Formula Disease Interactions
There are 6 disease interactions with Terbinex with Eco Formula (hydroxypropyl chitosan / terbinafine topical).
Terbinafine (applies to Terbinex with Eco Formula) liver disease
Major Potential Hazard, High plausibility.
Oral terbinafine is not recommended for use in patients with chronic or active liver disease. Terbinafine may be hepatotoxic. Rare cases of cholestatic hepatitis and liver failure, some resulting in liver transplant or death, have been reported during treatment of various dermatologic conditions in patients with and without preexisting liver disease. Although a causal relationship has not been established, the severity of hepatic events and/or their outcome may be worse in patients with active or chronic liver disease.
Terbinafine (applies to Terbinex with Eco Formula) neutropenia
Major Potential Hazard, Low plausibility.
Isolated cases of severe neutropenia have been reported in patients administered oral terbinafine. A causal relationship has not been established, although the neutropenia resolved following discontinuation of terbinafine with or without supportive care. Therapy with terbinafine should be administered cautiously in patients with preexisting neutropenia. It may be appropriate to monitor blood counts more frequently during terbinafine therapy. If secondary infection occurs and the neutrophil count is <= 1000 cells/mm3, terbinafine should be discontinued and supportive management initiated.
Terbinafine (applies to Terbinex with Eco Formula) depression
Moderate Potential Hazard, Moderate plausibility.
Postmarketing studies have reported depressive symptoms with the use of terbinafine tablets. Terbinafine should be used with caution in patients with depression, and prescribers should be alert to the development of depressive symptoms. Patients and caregivers should be instructed to report any depressive symptoms.
Terbinafine (applies to Terbinex with Eco Formula) immunosuppression
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Immunodeficiency
Transient decreases in absolute lymphocyte counts have been reported with oral terbinafine during clinical trials. The clinical significance of these decreases is unknown. Monitoring of complete blood counts may be appropriate in patients with known or suspected immunodeficiency receiving terbinafine for greater than six weeks.
Terbinafine (applies to Terbinex with Eco Formula) lupus
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Lupus Erythematosus
Precipitation and exacerbation of cutaneous and systemic lupus erythematosus has been reported postmarketing in patients taking terbinafine tablets. Terbinafine should be discontinued in patients with any clinical signs and symptoms suggestive of lupus erythematosus.
Terbinafine (applies to Terbinex with Eco Formula) renal dysfunction
Moderate Potential Hazard, Moderate plausibility.
The use of oral terbinafine in patients with renal impairment (CrCl <= 50 mL/min) has not been adequately studied and is, therefore, not recommended. Terbinafine metabolites are primarily eliminated by the kidney. The clinical significance of possible metabolite accumulation due to decreased clearance is unknown.
Switch to professional interaction data
Terbinex with Eco Formula drug interactions
There are 156 drug interactions with Terbinex with Eco Formula (hydroxypropyl chitosan / terbinafine topical).
Terbinex with Eco Formula alcohol/food interactions
There is 1 alcohol/food interaction with Terbinex with Eco Formula (hydroxypropyl chitosan / terbinafine topical).
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Cruex
Cruex is used for onychomycosis, tinea corporis, tinea cruris, tinea pedis
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Tineacide
Tineacide is used for tinea corporis, tinea cruris, tinea pedis
Lamisil
Lamisil (terbinafine) is used to treat infections caused by fungus that affect the fingernails or ...
Penlac
Penlac nail lacquer (ciclopirox) is used to treat fungal infections of the toenails and ...
Sporanox
Sporanox (itraconazole) is used to treat fungal infections of the lungs, mouth, throat, toenails ...
Ciclodan
Ciclodan is used for cutaneous candidiasis, onychomycosis, fingernail, onychomycosis, toenail ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.